StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)

Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –

Stryker Standalone Sub-Portfolio: Neuro Cranial by Year

Standalone Sub-Portfolio: Neuro Cranial — Worldwide Net Sales ($M) ($M)

Stryker Standalone Sub-Portfolio: Neuro Cranial: $2,485M in FY2025, up 16.3% from a year earlier.

Latest, FY2025
2,485
Period ended Dec 31, 2025
Change on a year earlier
+16.3%
2,136 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below

Where the FY2025 figure comes from

Q4 2025 derived via FY − 9M on identical recast basis.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStandalone Sub-Portfolio: Neuro Cranial — Worldwide Net Sales ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,485+16.3%0000310764-26-000041|syk-20260626_d2.htm ↗
FY2024Dec 31, 20242,136+13.9%0000310764-26-000041|syk-20260626_d2.htm ↗
FY2023Dec 31, 20231,876+36.3%0000310764-26-000041|syk-20260626_d2.htm ↗
FY2022Dec 31, 20221,376+13.3%0000310764-23-000005|sykex991earningsq42022.htm ↗
FY2021Dec 31, 20211,214+24.9%0000310764-22-000008|sykex991earningsq42021.htm ↗
FY2020Dec 31, 2020972-8.2%0000310764-22-000008|sykex991earningsq42021.htm ↗
FY2019Dec 31, 20191,059–0000310764-22-000028|syk-20211231.htm ↗

Breakdown

What makes up standalone Sub-Portfolio: Neuro Cranial

Cite this data

StockData. (2026). Stryker Standalone Sub-Portfolio: Neuro Cranial ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/sub-neuro-cranial-ww

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?